Tech

Sam Bankman-Fried's lawyers say he needs more Adderall to concentrate in court

Sam Bankman-Fried.
Former FTX CEO Sam Bankman-Fried. Angela Weiss/AFP via Getty Images
Read in app

Sam Bankman-Fried's lawyers say the embattled FTX founder needs more Adderall so he can concentrate during his ongoing criminal trial.

Bankman-Fried was diagnosed with ADHD and depression years ago, according to a story published by The New Yorker last month. Prescription drug Adderall helps to treat attention deficit hyperactivity disorder by improving one's attention and focus

Bankman-Fried's lawyers wrote in a letter to District Judge Lewis Kaplan on Sunday that their client "has been doing his best to remain focused during the trial for the past two weeks, despite not having his prescribed dose of Adderall during trial hours." 

The lawyers wrote that Bankman-Fried had only been given a dose of Adderall in the early mornings before he arrived at court for his criminal trial. The early dose would wear off by the time the trial began, his lawyers said.

The lawyers said they were concerned Bankman-Fried would not be able "to concentrate at the level he ordinarily would" without access to more Adderall.

Bankman-Fried's legal team proposed in the letter that their client be given an extended-release dose of Adderall before he is taken to court on Monday. They also suggested adjourning the trial for a day if the court couldn't provide the necessary medication.

A representative for Bankman-Fried declined to comment on the court petition. 

This isn't the first time Bankman-Fried has gotten his lawyers to petition for greater access to Adderall.

When Bankman-Fried was detained in the Metropolitan Detention Center in Brooklyn in August, his attorney asked Kaplan to grant Bankman-Fried "uninterrupted access" to Adderall, per court documents seen by Insider. 

Mark Cohen, one of Bankman-Fried's lawyers, told Kaplan in a letter on August 14 that Bankman-Fried "has been prescribed Adderall 10mg tablets, 3-4x/day" to treat his ADHD. Kaplan had approved Cohen's request for continued access to Bankman-Fried's medication.

The criminal trial against the disgraced crypto entrepreneur began on October 3. Prosecutors accuse Bankman-Fried of defrauding customers and investors of his now-bankrupt cryptocurrency exchange, FTX, by siphoning their funds to his trading firm, Alameda Research.

Bankman-Fried faces seven criminal charges ranging from securities fraud to money laundering. He has pled not guilty on all counts.

Read next

Kwan Wei Kevin Tan
Kwan Wei Kevin Tan
Kevin was a reporter at Business Insider's Singapore bureau. He reported primarily on the ins and outs of the business world, whether it be breaking news, covering CEO moves, tracking quarterly earnings, or writing explainers.He also covered careers and workplace issues, and has written about career transitions, the FIRE lifestyle, the college internship arms race, and the job hunt struggles faced by computer science majors.BackgroundKevin joined Business Insider's Singapore bureau in 2023. Before that, he was a civil servant at Singapore's Ministry of Sustainability and the Environment. He was appointed to the Singapore government's Public Service Leadership Programme, a talent development programme that develops capable and talented individuals for key leadership positions in the public service.Kevin’s journalism career began in college, where he first worked as a researcher for Channel NewsAsia and The Economist, and later as an intern reporter at Bloomberg News. In 2017, the Queen Elizabeth Diamond Jubilee Trust awarded him the Leading Change Journalism Bursary. His stories have appeared in numerous publications, including Fortune, The Japan Times, and The Edge Singapore.Kevin holds a bachelor’s degree in business administration from the National University of Singapore, where he was an NUS Merit Scholar. He was also the recipient of the PwC Whole Leadership Award, the NTUC Income Prize, the CFA Singapore Prize, and the Outstanding Undergraduate Researcher Prize.